HYPERLIPIDEMIA, FATTY LIVER, AND BROMSULFOPHTHALEIN RETENTION IN RABBITS INJECTED INTRAVENOUSLY WITH BACTERIAL ENDOTOXINS.
D001774:Blood Chemical Analysis; D002784:Cholesterol / Q000097:blood*; D004731:Endotoxins; D005227:Fatty Acids / Q000378:metabolism*; D005234:Fatty Liver; D005989:Glycerides; D006949:Hyperlipidemias; D050356:Lipid Metabolism; D008070:Lipopolysaccharides; D008168:Lung; D010336:Pathology; D010600:Pharmacology; D010743:Phospholipids; D011135:Polysaccharides, Bacterial; D011817:Rabbits; D012106:Research; D012790:Shwartzman Phenomenon; D013154:Spleen; D013448:Sulfobromophthalein
D004731:Endotoxins; D005227:Fatty Acids; D005989:Glycerides; D008070:Lipopolysaccharides; D010743:Phospholipids; D011135:Polysaccharides, Bacterial; D013448:Sulfobromophthalein; D002784:Cholesterol
BLOOD CHEMICAL ANALYSIS; BLOOD CHOLESTEROL; ENDOTOXINS; EXPERIMENTAL LAB STUDY; FATTY ACID METABOLISM; FATTY LIVER; GLYCERIDES; HYPERLIPEMIA; LIPOPOLYSACCHARIDES; LUNG; PATHOLOGY; PHARMACOLOGY; PHOSPHOLIPIDS; POLYSACCHARIDES, BACTERIAL; RABBITS; SHWARTZMAN PHENOMENON; SPLEEN; SULFOBROMOPHTHALEIN